1. Home
  2. |Insights
  3. |Claim Construction Under the BRI Standard: Can An "Incorrect" Interpretation Still Be "Reasonable"?

Claim Construction Under the BRI Standard: Can An "Incorrect" Interpretation Still Be "Reasonable"?

Client Alert | less than 1 min read | 04.14.20

Insights

Client Alert | 14 min read | 12.22.25

European Commission Proposes Biotech Act to Boost Health Biotechnology in the EU

On December 16, 2025, the European Commission published its proposal for a regulation establishing a European Biotech Act to strengthen the EU's biotechnology and biomanufacturing sectors with a primary focus on health....